Skip to main content
Smart Investors Daily
ME

NYSE · MED

Medifast, Inc.

Consumer Cyclical · Personal Products & Services

$11.98

Down-$0.23 (-1.92%)

Updated Nov 21, 2026, 12:01 AM

SID Score

4.2/10

Composite research score

Smart Money

—

Institutional and insider signal

Market cap
129.97M
P/E ratio
524.07
Dividend yield
0.00%
52-week range
$9.22 – $13.63
Volume
167.54K
Avg. volume
173.31K

Price performance · MED

MED price history

1M range · 20 trading sessions · Daily adjusted prices

Prices through Nov 19, 2026

MED closed at $11.98 after 20 trading sessions, up 0.93% for the selected period.

Last close
$11.98
Period change
+0.93%
Period low
$11.87
Period high
$13.37
Daily close
View OHLC price history
MED OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Nov 19, 2026$12.19$12.19$11.85$11.98167.54K
Nov 18, 2026$12.13$12.27$11.95$12.2088.96K
Nov 17, 2026$12.56$12.635$12.16$12.1970.36K
Nov 16, 2026$12.98$12.98$12.26$12.54161.71K
Nov 13, 2026$12.95$13.015$12.77$12.9767.34K
Nov 12, 2026$13.02$13.16$12.81$12.8686.31K
Nov 11, 2026$13.05$13.29$13.02$13.1384.95K
Nov 10, 2026$13.32$13.45$13.01$13.03111.97K
Nov 9, 2026$12.92$13.63$12.83$13.37147.13K
Nov 6, 2026$12.64$12.94$12.64$12.8189.71K
Nov 5, 2026$13.08$13.22$12.47$12.73152.1K
Nov 4, 2026$12.82$13.17$12.8001$13.15127.07K
Nov 3, 2026$12.61$12.85$12.5089$12.59123.79K
Nov 2, 2026$12.36$12.58$12.245$12.5393.65K
Oct 30, 2026$12.24$12.48$12.00$12.15231.9K
Oct 29, 2026$12.28$12.52$12.16$12.26124.45K
Oct 28, 2026$12.52$12.6359$12.13$12.28192.75K
Oct 27, 2026$12.20$12.93$12.20$12.49177.08K
Oct 26, 2026$13.00$13.41$11.87$12.11306.37K
Oct 23, 2026$12.10$12.10$11.67$11.87110.31K

Latest MED news

The latest Smart Investors Daily articles mentioning MED.

MED research

Overview

Company profile and research snapshot.

Company profile

Medifast Inc is a old health and wellness company known for its habit-based and coach-guided lifestyle solution OPTAVIA, which provides people with a simple, yet comprehensive approach to address obesity and support a healthy life. OPTAVIA provides unparalleled coaching support along with community, tailored nutrition and healthy habits, and empowers people to master their weight loss journey through each stage of life. The company has access to GLP-1 medications where clinically appropriate. Medifast remains committed to its mission of offering Lifelong Transformation, Making a Healthy Lifestyle Second Nature.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
—
Average target
$83.50
Implied upside
—
Analysts
—
MED recent ratings
DateFirmRatingTarget
Feb 19, 2026Stephens & Co.Equal-Weight—
Feb 19, 2025DA DavidsonNeutral—
Nov 5, 2024DA DavidsonNeutral—
Jul 22, 2024DA DavidsonUnderperform—
Jun 5, 2024DA DavidsonUnderperform—
Open full forecast

News briefing

No generated briefing is available yet.

SeekingAlpha · May 12, 2026

Medifast: Worth Putting On A Watchlist

Medifast has continued to report concerning financials. A shrinking coach network lowers revenues, and costs remain too high. See why MED stock is a Hold.

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.